Prevention of hemoperitoneum during ovulation by oral contraceptives in women with type III von Willebrand disease and afibrinogenemia. Case reports

E. Bottini, F. I. Pareti, D. Mari, P. M. Mannucci, M. L. Muggiasca, M. Conti

Research output: Contribution to journalArticle

Abstract

The follicle ruptures at the time of ovulation and fills with blood, forming a corpus hemorrhagicum. Minor bleeding from the follicle into the abdominal cavity may cause peritoneal irritation and, when occurring in a patient with a defect of primary hemostasis, hemoperitoneum can occur. Von Willebrand disease and afibrinogenemia are 2 important bleeding disorders in which both primary hemostasis and coagulation are involved. Bleeding during ovulation is 1 major clinical complication in women with these diseases. The authors examined 3 patients with this hemorrhagic complication and data show that oral contraceptives are an effective means to avoid hemoperitoneum. author's modified

Original languageEnglish
Pages (from-to)431-433
Number of pages3
JournalHaematologica
Volume76
Issue number5
Publication statusPublished - 1991

Fingerprint

Afibrinogenemia
Hemoperitoneum
von Willebrand Diseases
Oral Contraceptives
Ovulation
Hemorrhage
Hemostasis
Abdominal Cavity
Rupture

ASJC Scopus subject areas

  • Hematology

Cite this

Prevention of hemoperitoneum during ovulation by oral contraceptives in women with type III von Willebrand disease and afibrinogenemia. Case reports. / Bottini, E.; Pareti, F. I.; Mari, D.; Mannucci, P. M.; Muggiasca, M. L.; Conti, M.

In: Haematologica, Vol. 76, No. 5, 1991, p. 431-433.

Research output: Contribution to journalArticle

@article{d948d64de7e74453ad4c3c8e55ec88d9,
title = "Prevention of hemoperitoneum during ovulation by oral contraceptives in women with type III von Willebrand disease and afibrinogenemia. Case reports",
abstract = "The follicle ruptures at the time of ovulation and fills with blood, forming a corpus hemorrhagicum. Minor bleeding from the follicle into the abdominal cavity may cause peritoneal irritation and, when occurring in a patient with a defect of primary hemostasis, hemoperitoneum can occur. Von Willebrand disease and afibrinogenemia are 2 important bleeding disorders in which both primary hemostasis and coagulation are involved. Bleeding during ovulation is 1 major clinical complication in women with these diseases. The authors examined 3 patients with this hemorrhagic complication and data show that oral contraceptives are an effective means to avoid hemoperitoneum. author's modified",
author = "E. Bottini and Pareti, {F. I.} and D. Mari and Mannucci, {P. M.} and Muggiasca, {M. L.} and M. Conti",
year = "1991",
language = "English",
volume = "76",
pages = "431--433",
journal = "Haematologica",
issn = "0390-6078",
publisher = "NLM (Medline)",
number = "5",

}

TY - JOUR

T1 - Prevention of hemoperitoneum during ovulation by oral contraceptives in women with type III von Willebrand disease and afibrinogenemia. Case reports

AU - Bottini, E.

AU - Pareti, F. I.

AU - Mari, D.

AU - Mannucci, P. M.

AU - Muggiasca, M. L.

AU - Conti, M.

PY - 1991

Y1 - 1991

N2 - The follicle ruptures at the time of ovulation and fills with blood, forming a corpus hemorrhagicum. Minor bleeding from the follicle into the abdominal cavity may cause peritoneal irritation and, when occurring in a patient with a defect of primary hemostasis, hemoperitoneum can occur. Von Willebrand disease and afibrinogenemia are 2 important bleeding disorders in which both primary hemostasis and coagulation are involved. Bleeding during ovulation is 1 major clinical complication in women with these diseases. The authors examined 3 patients with this hemorrhagic complication and data show that oral contraceptives are an effective means to avoid hemoperitoneum. author's modified

AB - The follicle ruptures at the time of ovulation and fills with blood, forming a corpus hemorrhagicum. Minor bleeding from the follicle into the abdominal cavity may cause peritoneal irritation and, when occurring in a patient with a defect of primary hemostasis, hemoperitoneum can occur. Von Willebrand disease and afibrinogenemia are 2 important bleeding disorders in which both primary hemostasis and coagulation are involved. Bleeding during ovulation is 1 major clinical complication in women with these diseases. The authors examined 3 patients with this hemorrhagic complication and data show that oral contraceptives are an effective means to avoid hemoperitoneum. author's modified

UR - http://www.scopus.com/inward/record.url?scp=0025750775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025750775&partnerID=8YFLogxK

M3 - Article

C2 - 1806451

AN - SCOPUS:0025750775

VL - 76

SP - 431

EP - 433

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 5

ER -